Assessing risk and benefit: To treat or not to treat major depression during pregnancy with antidepressant medication

American Journal of Psychiatry

Volumn 166, Issue 5, 2009, Pages 512-514

  Parry, Barbara L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

DEPRESSION; DRUG EFFECT; EDITORIAL; MAJOR DEPRESSION; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PUERPERAL DEPRESSION; RISK ASSESSMENT; RISK BENEFIT ANALYSIS;

CHILD OF IMPAIRED PARENTS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; PREGNANCY; PREGNANCY COMPLICATIONS; RECURRENCE; RISK ASSESSMENT; SEROTONIN UPTAKE INHIBITORS; WEIGHT GAIN;

EID: 66149175595     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2009.09020251     Document Type: Editorial

References (12)

1. Wisner KL, Sit DKY, Hanusa BH, Moses-Kolko EL, Bogen DL, Hunker DF, Perel JM, Jones-Ivy S, Bodnar LM, Singer LT: Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes. Am J Psychiatry 2009; 166:557-566
2. Moster D, Lie RT, Markestad T: Long-term medical and social consequences of preterm birth. N Engl J Med 2008; 359:262-273
3. Nulman I, Rovet J, Stewart DE, Wolpin J, Pace-Asciak P, Shuhaiber S, Koren G: Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry 2002; 159:1889-1895
4. Weissman MM, Wickramaratne P, Nomura Y, Warner V, Pilowsky D, Verdeli H: Offspring of depressed parents: 20 years later. Am J Psychiatry 2006; 163:1001-1008
5. Weissman MM, Pilowsky DJ, Wickramaratne PJ, Talati A, Wisniewski SR, Fava M, Hughes CW, Garber J, Malloy E, King CA, Cerda G, Sood AB, Alpert JE, Trivedi MH, Rush AJ: Remissions in maternal depression and child psychopathology: a STAR*D-Child report. JAMA 2006; 295:1389-1398
6. Halligan SL, Herbert J, Goodyer I, Murray L: Disturbances in morning cortisol secretion in association with maternal postnatal depression predict subsequent depressive symptomatology in adolescents. Biol Psychiatry 2007; 62:40-46
7. Murray L, Woolgar M, Cooper PJ, Hipwell A: Cognitive vulnerability in five year old children of depressed mothers. J Child Psychol Psychiatry 2001; 42:891-899
8. Murray L, Halligan SL, Adams G, Patterson P, Goodyer IM: Socioemotional development in adolescents at risk for depression: the role of maternal depression and attachment style. Dev Psychopathol 2006; 18:489-516
9. Andersson L, Sundstrom-Poromaa I, Wulff M, Astrom M, Bixo M: Depression and anxiety during pregnancy and six months postpartum: a follow-up study. Acta Obstet Gynecol Scand 2006; 85:937-944
10. Halligan SL, Murray L, Martins C, Cooper PJ: Maternal depression and psychiatric outcomes in adolescent offspring: a 13-year longitudinal study. J Affect Disord 2007; 97:145-154
11. Einarson A, Pistelli A, DeSantis M, Malm H, Paulus WD, Panchaud A, Kennedy D, Einarson TR, Koren G: Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy. Am J Psychiatry 2008; 165:749-752
12. Andrade SE, McPhillips H, Loren D, Raebel MA, Lane K, Livingston J, Boudreau DM, Smith DH, Davis RL, Willy ME, Platt R: Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn. Pharmacoepidemiol Drug Saf 2009; 18:246-252